文献速递头颈外科

老年头颈鳞癌的治疗方式、不良事件与生存结局

Treatment modalities, adverse events, and survival outcomes in older patients with head and neck squamous cell carcinoma.
PubMed 文献 · Head Neck · 2021-10-10

基于SEER-Medicare数据库的原发性头颈鳞癌回顾性研究,比较不同治疗与年龄组的总生存和不良事件。在全部5879例及≥80岁组1380例中,放化疗较单纯放疗均与更好OS相关(HR=0.82,p<0.001;HR=0.77,p=0.006),且最年长组不良事件率不高于66-69岁组。

要点

  • 放化疗较单纯放疗与更好OS相关,最年长组亦如此。
  • ≥80岁组不良事件率不高于66-69岁组。
  • 年轻组放化疗使用比例(26%-30%)高于最年长组(14%-19%)。

核心结论

  • 放化疗较单纯放疗与老年头颈鳞癌患者更好OS相关,最年长组亦如此。
  • 选择最佳治疗应同等考虑患者特征而非仅按实际年龄。

研究设计与样本

  • 回顾性队列研究,数据来自SEER-Medicare关联数据库的原发性头颈鳞癌病例。
  • 按四个年龄组分析,包括最年轻组66-69岁和最年长组≥80岁。

主要发现

  • 全部患者(N=5879)中,放化疗较单纯放疗与更好OS相关(HR=0.82,p<0.001)。
  • 最年长组(N=1380)中,放化疗较单纯放疗与更好OS相关(HR=0.77,p=0.006)。
  • 最年长组不良事件率不高于最年轻组(N=1562)。
  • 最年轻组接受放化疗比例(26%-30%)高于最年长组(14%-19%),与合并症指数无关。

临床怎么用

  • 老年头颈鳞癌选择治疗时,应综合评估患者特征,不应仅依据实际年龄。
  • 对≥80岁患者,放化疗可与更好OS相关且不良事件率未高于较年轻组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chemoradiation with curative intent in older adults with locally advanced head and neck squamous cell carcinoma (HNSCC) has been a challenge, because of its potential toxicities. METHODS: We selected primary HNSCC cases from the SEER-Medicare linked database, assessed overall survival (OS) and adverse events and their associations with different treatments, across four age groups including the youngest (66-69 years) and the oldest (≥80 years). RESULTS: Better OS was associated with chemoradiation compared to radiation alone, not only in all patients (N = 5879) (hazard ratio [HR] = 0.82, p < 0.001), but also in the oldest group (N = 1380) (HR = 0.77, p = 0.006) in whom the adverse events rates were not higher than those in the youngest (N = 1562); more of the latter (26%-30%) than the former (14%-19%) received chemoradiation, regardless of their comorbidity indices. CONCLUSIONS: Our findings provide evidence that patients' characteristics, other than chronological age, should be equally considered in selecting the best therapy for older patients with HNSCC.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Amr S, Ioffe D, Suzuki I, et al. Treatment modalities, adverse events, and survival outcomes in older patients with head and neck squamous cell carcinoma. Head Neck. 2021. PMID: 34632677. doi:10.1002/hed.26893

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。